Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model

S. Modok, R. Scott, R. A. Alderden, M. D. Hall, H. R. Mellor, S. Bohic, T. Roose, T. W. Hambley, R. Callaghan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Four-coordinate (Pt(II)) platinum-based anticancer drugs are widely used in primary or palliative chemotherapy and produce considerable efficacy in certain clinical applications, for example testicular cancer. However, in many cancers the Pt(II) drugs are beset by poor efficacy mainly due to suboptimal pharmacokinetic properties. Consequently, the six-coordinate (Pt(IV)) class of Pt drugs were developed to improve platinum efficacy by (i) increasing stability, (ii) reducing reactivity, (iii) increasing lipophilicity, and (iv) nuclear targeting. However, comparatively little information is available on the pharmacokinetic properties of these compounds within solid tumour tissue. In the present study, the distribution and fluxes of [14C]-labelled [PtCl2(en)] (where en stands for ethane-1,2-diamine) and cis,trans-[PtCl2(OH)2(en)] drugs were determined in the multicell layer (MCL) tumour model comprising colon cancer cells. Flux data were analysed by mathematical modelling of drug diffusion and cellular uptake in the transport system. The flux of the Pt(IV) compound through the MCL was not significantly different to that of the Pt(II) drug nor were the diffusion coefficient or tissue uptake; the latter confirmed with elemental imaging analysis by synchrotron radiation induced X-ray emission. However, the flux of the Pt(IV) through the MCL was increased by hydrostatic pressure, thereby demonstrating the potential to target cancer cells further away from the vessels with six-coordinate platinum drugs.

Original languageEnglish
Pages (from-to)194-200
Number of pages7
JournalBritish Journal of Cancer
Volume97
Issue number2
DOIs
Publication statusPublished - Jul 10 2007

Fingerprint

Platinum Compounds
Platinum
Pharmaceutical Preparations
Neoplasms
ethylenediamine
Pharmacokinetics
Synchrotrons
Hydrostatic Pressure
Drug Design
Testicular Neoplasms
Colonic Neoplasms
X-Rays
Radiation
Drug Therapy

Keywords

  • 3D tumour model
  • Cisplatin
  • Convection
  • Diffusion
  • Drug delivery
  • Multicell layer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model. / Modok, S.; Scott, R.; Alderden, R. A.; Hall, M. D.; Mellor, H. R.; Bohic, S.; Roose, T.; Hambley, T. W.; Callaghan, R.

In: British Journal of Cancer, Vol. 97, No. 2, 10.07.2007, p. 194-200.

Research output: Contribution to journalArticle

Modok, S, Scott, R, Alderden, RA, Hall, MD, Mellor, HR, Bohic, S, Roose, T, Hambley, TW & Callaghan, R 2007, 'Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model', British Journal of Cancer, vol. 97, no. 2, pp. 194-200. https://doi.org/10.1038/sj.bjc.6603854
Modok, S. ; Scott, R. ; Alderden, R. A. ; Hall, M. D. ; Mellor, H. R. ; Bohic, S. ; Roose, T. ; Hambley, T. W. ; Callaghan, R. / Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model. In: British Journal of Cancer. 2007 ; Vol. 97, No. 2. pp. 194-200.
@article{0f1675c70eb1428da43885a69e45f3df,
title = "Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model",
abstract = "Four-coordinate (Pt(II)) platinum-based anticancer drugs are widely used in primary or palliative chemotherapy and produce considerable efficacy in certain clinical applications, for example testicular cancer. However, in many cancers the Pt(II) drugs are beset by poor efficacy mainly due to suboptimal pharmacokinetic properties. Consequently, the six-coordinate (Pt(IV)) class of Pt drugs were developed to improve platinum efficacy by (i) increasing stability, (ii) reducing reactivity, (iii) increasing lipophilicity, and (iv) nuclear targeting. However, comparatively little information is available on the pharmacokinetic properties of these compounds within solid tumour tissue. In the present study, the distribution and fluxes of [14C]-labelled [PtCl2(en)] (where en stands for ethane-1,2-diamine) and cis,trans-[PtCl2(OH)2(en)] drugs were determined in the multicell layer (MCL) tumour model comprising colon cancer cells. Flux data were analysed by mathematical modelling of drug diffusion and cellular uptake in the transport system. The flux of the Pt(IV) compound through the MCL was not significantly different to that of the Pt(II) drug nor were the diffusion coefficient or tissue uptake; the latter confirmed with elemental imaging analysis by synchrotron radiation induced X-ray emission. However, the flux of the Pt(IV) through the MCL was increased by hydrostatic pressure, thereby demonstrating the potential to target cancer cells further away from the vessels with six-coordinate platinum drugs.",
keywords = "3D tumour model, Cisplatin, Convection, Diffusion, Drug delivery, Multicell layer",
author = "S. Modok and R. Scott and Alderden, {R. A.} and Hall, {M. D.} and Mellor, {H. R.} and S. Bohic and T. Roose and Hambley, {T. W.} and R. Callaghan",
year = "2007",
month = "7",
day = "10",
doi = "10.1038/sj.bjc.6603854",
language = "English",
volume = "97",
pages = "194--200",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model

AU - Modok, S.

AU - Scott, R.

AU - Alderden, R. A.

AU - Hall, M. D.

AU - Mellor, H. R.

AU - Bohic, S.

AU - Roose, T.

AU - Hambley, T. W.

AU - Callaghan, R.

PY - 2007/7/10

Y1 - 2007/7/10

N2 - Four-coordinate (Pt(II)) platinum-based anticancer drugs are widely used in primary or palliative chemotherapy and produce considerable efficacy in certain clinical applications, for example testicular cancer. However, in many cancers the Pt(II) drugs are beset by poor efficacy mainly due to suboptimal pharmacokinetic properties. Consequently, the six-coordinate (Pt(IV)) class of Pt drugs were developed to improve platinum efficacy by (i) increasing stability, (ii) reducing reactivity, (iii) increasing lipophilicity, and (iv) nuclear targeting. However, comparatively little information is available on the pharmacokinetic properties of these compounds within solid tumour tissue. In the present study, the distribution and fluxes of [14C]-labelled [PtCl2(en)] (where en stands for ethane-1,2-diamine) and cis,trans-[PtCl2(OH)2(en)] drugs were determined in the multicell layer (MCL) tumour model comprising colon cancer cells. Flux data were analysed by mathematical modelling of drug diffusion and cellular uptake in the transport system. The flux of the Pt(IV) compound through the MCL was not significantly different to that of the Pt(II) drug nor were the diffusion coefficient or tissue uptake; the latter confirmed with elemental imaging analysis by synchrotron radiation induced X-ray emission. However, the flux of the Pt(IV) through the MCL was increased by hydrostatic pressure, thereby demonstrating the potential to target cancer cells further away from the vessels with six-coordinate platinum drugs.

AB - Four-coordinate (Pt(II)) platinum-based anticancer drugs are widely used in primary or palliative chemotherapy and produce considerable efficacy in certain clinical applications, for example testicular cancer. However, in many cancers the Pt(II) drugs are beset by poor efficacy mainly due to suboptimal pharmacokinetic properties. Consequently, the six-coordinate (Pt(IV)) class of Pt drugs were developed to improve platinum efficacy by (i) increasing stability, (ii) reducing reactivity, (iii) increasing lipophilicity, and (iv) nuclear targeting. However, comparatively little information is available on the pharmacokinetic properties of these compounds within solid tumour tissue. In the present study, the distribution and fluxes of [14C]-labelled [PtCl2(en)] (where en stands for ethane-1,2-diamine) and cis,trans-[PtCl2(OH)2(en)] drugs were determined in the multicell layer (MCL) tumour model comprising colon cancer cells. Flux data were analysed by mathematical modelling of drug diffusion and cellular uptake in the transport system. The flux of the Pt(IV) compound through the MCL was not significantly different to that of the Pt(II) drug nor were the diffusion coefficient or tissue uptake; the latter confirmed with elemental imaging analysis by synchrotron radiation induced X-ray emission. However, the flux of the Pt(IV) through the MCL was increased by hydrostatic pressure, thereby demonstrating the potential to target cancer cells further away from the vessels with six-coordinate platinum drugs.

KW - 3D tumour model

KW - Cisplatin

KW - Convection

KW - Diffusion

KW - Drug delivery

KW - Multicell layer

UR - http://www.scopus.com/inward/record.url?scp=34447341225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447341225&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6603854

DO - 10.1038/sj.bjc.6603854

M3 - Article

VL - 97

SP - 194

EP - 200

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -